openPR Logo
Press release

DiGeorge Syndrome Drug Market Upcoming Scope and Challenges 2026| Aevi Genomic Medicine, Inc, Bausch Health, Natera, Inc, Roche Sequencing, Enzyvant

03-04-2020 06:09 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

DiGeorge Syndrome Drug Market

DiGeorge Syndrome Drug Market

Data Bridge Market Research has added an exhaustive research study of the Global DiGeorge Syndrome Drug Market detailing every single market driver and intricately analyzing the business vertical. The research report has abilities to rise as the most significant market worldwide as it has remained to play a remarkable role in establishing progressive impacts on the universal economy. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry-validated market data. Some are the key players taken under coverage for this study are Aevi Genomic Medicine, Inc, Bausch Health, Natera, Inc, Roche Sequencing, Enzyvant, Progenity, Inc., Boehringer Ingelheim International GmbH, AbbVie Inc., Amgen Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc, Angimmune LLC, Sumitomo Dainippon Pharma Co., Ltd., CELGENE CORPORATION, CELLECTAR BIOSCIENCES, INC, eFFECTOR Therapeutics, Inc., IMV Inc, Karyopharm, Neon Therapeutics, Novartis AG and many others

Global DiGeorge Syndrome Drug Market is framed with a bunch of Graphical Statistics, Tables and Figures, request for a sample: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-digeorge-syndrome-drug-market

Global DiGeorge syndrome drug market is expected to grow at a substantial CAGR in the forecast period of 2019-2026. Growing incidence of DiGeorge syndrome's population and the development of newer therapies and treatment are the key factors for market growth. Global DiGeorge Syndrome Drug Market By Therapy Type (Regenerative Medicine Advanced Therapy and Hormone Replacement Therapy), Treatment Type (Medication and Surgery), Route of Administration (Oral and Injectable), End- Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends & Forecast to 2026

Market Definition: Global DiGeorge Syndrome Drug Market

DiGeorge syndrome is also known as 22q11.2 deletion syndrome or velocardiofacial syndrome is a rare pediatric congenital condition where children are born with absence of chromosome 22. This results to severe immunodeficiency causing poor development of several body systems. Children with DiGeorge syndrome disorders have no ability to fight against infections.

According to the article puplished in Northwestern University, it is estimated that the incident population of DiGeorge Syndrome in the United States around 500 to 750 and over 2.5 million children diagnosed yearly. These growing incidents of DiGeorge syndrome's population worldwide and robust pipeline for development of newer therapies are the key factors for market growth.

Market Drivers

Vulnerable pediatric population of DiGeorge syndrome

Emergence of drugs for treating serious disease such as CNS disorders and cardiovascular diseases associated with DiGeorge syndrome

Increase in the rate of R&D initiatives is driving DiGeorge syndrome therapeutics market

Market Restraints

Effective treatment is either unavailable or unaffordable

Patent expiry from many companies and introduction of generic drugs of branded version is expected to restrain the growth if the market

Inadequate knowledge about DiGeorge syndrome in some developing countries

Segmentation: Global DiGeorge Syndrome Drug Market

By Therapy Type

Regenerative Medicine Advanced Therapy

Hormone Replacement Therapy

By Treatment

Medication

Vitamin D and Calcium

Surgery

Palatoplasty

Heart defects

Others

By Route of administration

Oral

Injectable

By End Users

Hospitals

Homecare

Specialty Clinics

Others

By Geography

North America

South America

Europe

Asia-Pacific

Middle East & Africa

Order a Copy of This Research Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-digeorge-syndrome-drug-market

Key Developments in the Market:

In June 2019, Enzyvant's drug candidate RVT-802, a tissue-based regenerative therapy received the FDA acceptance of Biologic License Application (BLA) as well as Priority Review status for the treatment of pediatric congenital athymia associated with complete DiGeorge Anomaly (cDGA), CHARGE syndrome, and FOXN1 deficiency. If approved, it will be the first drug used for the treatment of DiGeorge syndrome and turning it into a potential blockbuster commercial milestone for Enzyvant.

In September 2017, Enzyvant received Rare Pediatric Disease designation from the FDA for RVT-802, a tissue-based regenerative therapy for treatment of congenital athymia associated with complete DiGeorge Syndrome. The FDA Rare Pediatric Disease designation will enable to receive a rare pediatric disease priority review voucher upon approval of Biologic License Application (BLA).

Reasons to Purchase this Report

Current and future of global Digeorge syndrome drug market outlook in the developed and emerging markets

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

Regions/Countries that are expected to witness the fastest growth rates during the forecast period

The latest developments, market shares, and strategies that are employed by the major market players

Table of Content:

Study Coverage
Executive Summary
Market Size by Manufacturers
Production by Regions
Consumption by Regions
Market Size by Type
Market Size by Application
Manufacturers Profiles
Production Forecasts
Consumption Forecast
Upstream, Industry Chain and Downstream Customers Analysis
Opportunities & Challenges, Threat and Affecting Factors
Key Findings
Appendix

Download Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-digeorge-syndrome-drug-market

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release DiGeorge Syndrome Drug Market Upcoming Scope and Challenges 2026| Aevi Genomic Medicine, Inc, Bausch Health, Natera, Inc, Roche Sequencing, Enzyvant here

News-ID: 1953364 • Views:

More Releases from Data Bridge Market Research

Wind Turbine Operations and Maintenance Market is estimated to grow at a Potential Growth Rate of 11.30% by 2028
Wind Turbine Operations and Maintenance Market is estimated to grow at a Potenti …
Industry Analysis The rise in investment in offshore wind turbines is escalating the growth of wind turbine operations and maintenance market. Wind turbine operations and maintenance refer to the services of maintaining the smooth working of the wind turbines. Wind energy means a renewable form of energy which is widely available on the surface of earth. The wind energy is generated by the conversion of wind flow into any useful form of
Warehouse Robotics Market Exceed Valuation of CAGR of 15.25% by 2029
Warehouse Robotics Market Exceed Valuation of CAGR of 15.25% by 2029
Industry Analysis Data Bridge Market Research report on warehouse robotics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The rise in the demand in the deployment of robotic systems is escalating the growth of warehouse robotics market. Warehouse robotics is referred to as the deployment of robotics in the warehouse to achieve functions including
Hibiscus Flower Powder Market Size, Share, Trends, Growth, Strategies, Opportunities, Top Companies, Regional Analysis and Forecast
Hibiscus Flower Powder Market Size, Share, Trends, Growth, Strategies, Opportuni …
The trustworthy Hibiscus Flower Powder Market study details the key actions taken by the leading companies and brands, including innovations, product launches, mergers, joint ventures, acquisitions, and competitive analysis in the industry. This winning market paper can cover more ground than just market scenarios and main players' pricing comparisons. It's a comprehensive background study of the sector that also estimates the parental market. A top-notch Hibiscus Flower Powder Market research report
Caffeinated Beverage Market Business Opportunities, Future Industry Trends, Strategies, Revenue, Challenges, Top Players and Forecast
Caffeinated Beverage Market Business Opportunities, Future Industry Trends, Stra …
A crucial source of information, the Caffeinated Beverage Market Research Report provides approaching and current technological and financial aspects of the industry through 2030. For the benefit of readers and end users, all gathered market data is verified and confirmed by industry professionals. With the help of this reliable marketing report, analyzing the actions of major companies and their impact on sales, import, export, revenue, and CAGR numbers becomes simple. The

All 5 Releases


More Releases for DiGeorge

Global DiGeorge Syndrome Drug Market Report Forecast to 2021-2027 |key players a …
The chromosome 22 abnormality causes DiGeorge syndrome, which is a chromosomal condition. DiGeorge syndrome causes delays in the development of various body systems, as well as cardiac problems, impaired immunological function, a cleft palate, and low calcium levels in the blood. Clinics, patients, and other clinical benefits are available to enterprises associated with the DiGeorge Syndrome Drug Market industry. These organizations that provide clinical protection have become necessary and chosen support
DiGeorge Syndrome Drug Market Share, Trends, Future Scope, Forecast 2026| Aevi G …
The in-depth research report on DiGeorge Syndrome Drug Market added to its huge repository by DBMR provides imprehensive and all aspects of market research. The market insights of this market report helps with the successful launch of new product. The report efficiently gathers, analyzes and interprets information about a market, about a product or service to be offered for sale in that market. Potential customers for the product or service and
DiGeorge Syndrome Drug Market 2020 Share Analysis By Aevi Genomic Medicine, Inc, …
DiGeorge syndrome drug market is expected to grow at a substantial CAGR in the forecast period of 2019-2026. Growing incidence of DiGeorge syndrome’s population and the development of newer therapies and treatment are the key factors for market growth. Global DiGeorge Syndrome Drug Market By Therapy Type (Regenerative Medicine Advanced Therapy and Hormone Replacement Therapy), Treatment Type (Medication and Surgery), Route of Administration (Oral and Injectable), End- Users (Hospitals, Homecare, Specialty
DiGeorge Syndrome Drug Market 2020 Size, Share and Trend Analysis | Top Vendors …
The DiGeorge Syndrome Drug Market report lists and studies the leading competitors, as well as provides the insights with strategic industry analysis of the key factors influencing the market dynamics. In this report, the market is segmented according to type, application, end users, and region. Moreover, it presents granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. Each segment and sub-segment is studied carefully
DiGeorge Syndrome Drug Market 2020 Future Outlook | Key Players - Aevi Genomic M …
The primary sources employed while generating this DiGeorge Syndrome Drug Market report include the industry experts from the industry comprising the management corporation, processing organizations, analytical service suppliers of the industry's value chain. All primary sources are interviewed to accumulate the data and validate qualitative & quantitative information and conclude future prospects. Secondary research consists of key data about the industry value chain, the complete pool of major players, and
DiGeorge Syndrome Drug Market Worth Observing Growth : CELLECTAR BIOSCIENCES, IN …
The DiGeorge Syndrome Drug Market analysis report brings into focus studies about market definition, market segmentation, and competitive analysis in the market. The precise and state-of-the-art information provided via this report helps businesses get aware about the types of consumers, consumer's demands and preferences, their point of view about the product, their buying intentions, their response to particular product, and their varying tastes about the specific product already existing in